METASTATIC BREAST CARCINOMA
Clinical trials for METASTATIC BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breast cancer drug combo trial ends early – results limited
Disease control TerminatedThis study tested a mix of targeted drugs (neratinib, pertuzumab, trastuzumab) and chemotherapy (paclitaxel) in people with advanced or inflammatory breast cancer. The goal was to find the best dose and see if the combination could eliminate all signs of cancer before surgery. Th…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:12 UTC
-
Promising combo trial for aggressive breast cancer halted early
Disease control TerminatedThis study looked at adding a drug called copanlisib to standard targeted therapy (trastuzumab and pertuzumab) for people with advanced HER2-positive breast cancer that has a specific genetic change (PIK3CA or PTEN mutation). The goal was to see if the combination could shrink tu…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Could meal timing protect your brain during cancer treatment?
Symptom relief TerminatedThis study tested a mobile app that helps people with brain metastases from breast or lung cancer follow a time-restricted eating plan. The goal was to see if changing when they eat could reduce memory and thinking problems after radiation therapy. Only one person enrolled before…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC